Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in Insomnia Disorder
NCT07392177Phase 2Recruiting
- Sponsor
- Woolcock Institute of Medical Research
- Start
- Aug 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in Insomnia, sponsored by Woolcock Institute of Medical Research. Started Aug 2026; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT07392177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07392177.